Ticker Scorecard - ADMA Basics Company: ADMA Biologics Inc IPO Date: October 18, 2013 Sector: Healthcare Industry: Biotech Market Cap: $4.67B Activated in VL: True Average Daily Range Avg Daily Range: $0.14 | 2.80% Avg Daily Range (30 D): $0.47 | 2.89% Avg Daily Range (90 D): $0.48 | 2.66% Institutional Daily Volume Avg Daily Volume: 1.53M Avg Daily Volume (30 D): 2.23M Avg Daily Volume (90 D): 2.16M Trade Size Avg Trade Size (Sh.): 212 Avg Trade Size (Sh.) (30 D): 76 Avg Trade Size (Sh.) (90 D): 80 Institutional Trades Total Inst.Trades: 1,442 Avg Inst. Trade: $3.21M Avg Inst. Trade (30 D): $4.14M Avg Inst. Trade (90 D): $3.78M Avg Inst. Trade Volume: .35M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.6M Avg Closing Trade (30 D): $7.53M Avg Closing Trade (90 D): $8.26M Avg Closing Volume: 509.35K     News Mar 4, 2025 @ 6:50 PM BREAKING: Block & Leviton Investigating ADMA Biolo... Source: Block & Leviton Nov 2, 2024 @ 10:18 AM BFA Law is Investigating ADMA BIOLOGICS for Securi... Source: N/A Oct 27, 2024 @ 12:06 PM ADMA FRAUD ALERT: BFA Law Notifies ADMA Biologics ... Source: N/A Oct 19, 2024 @ 10:28 AM ADMA INVESTIGATION UPDATE: ADMA Biologics Investor... Source: N/A Oct 17, 2024 @ 3:00 PM ADMA Biologics ALERT: Securities Fraud Investigati... Source: Block & Leviton Financials   TTM Q4 2024 FY 2024 Basic EPS $.85 $.48 $.85 Diluted EPS $.81 $.46 $.81 Revenue $ 426.45M $ 117.55M $ 426.45M Gross Profit $ 219.55M $ 63.33M $ 219.55M Net Income / Loss $ 197.67M $ 111.9M $ 197.67M Operating Income / Loss $ 138.98M $ 38.32M $ 138.98M Cost of Revenue $ 206.9M $ 54.22M $ 206.9M Net Cash Flow $ 51.8M $ 16.44M $ 51.8M PE Ratio 24.51